{"id": "1352653600368062469", "creation": 1611332724.0, "user_id": "1323376684490514433", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 1, "like_count": 2, "quote_count": 0}}, "text": "\u201cVaxart should soon report results from a phase 1 study of VXA-CoV2-1. If those results are as encouraging as the experimental vaccine's preclinical data, the biotech's shares will almost certainly be off to the races.\u201d #VXRT #vaccine #COVID19 \n\nhttps://t.co/YA6A90ug48", "first_save": 1634559108.199414, "hashtags": ["#VXRT", "#VACCINE", "#COVID19"]}